MiniMed partners with Abbott to roll out Instinct CGM integration in Europe

MiniMed Group, Inc.
Medtronic Plc

MiniMed Group, Inc.

MMED

0.00

Medtronic Plc

MDT

0.00
  • MiniMed struck a collaboration with Abbott to integrate Abbott’s Instinct and Instinct Go continuous glucose sensors into its diabetes systems in Europe.
  • The rollout starts this month, pairing Instinct with MiniMed’s 780G automated insulin delivery system.
  • Instinct Go will integrate with MiniMed Go, linking InPen smart-pen dose tracking with real-time CGM data in one mobile app.
  • MiniMed is positioning the Abbott sensor tie-up as an expansion of user choice while keeping glycemic outcomes in line with its existing Simplera Sync sensor.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MiniMed Group Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606250959PR_NEWS_EURO_ND__NL88064) on June 25, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.